These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1525 related articles for article (PubMed ID: 25452219)

  • 1. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.
    Boellaard R; Delgado-Bolton R; Oyen WJ; Giammarile F; Tatsch K; Eschner W; Verzijlbergen FJ; Barrington SF; Pike LC; Weber WA; Stroobants S; Delbeke D; Donohoe KJ; Holbrook S; Graham MM; Testanera G; Hoekstra OS; Zijlstra J; Visser E; Hoekstra CJ; Pruim J; Willemsen A; Arends B; Kotzerke J; Bockisch A; Beyer T; Chiti A; Krause BJ;
    Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):328-54. PubMed ID: 25452219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
    Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
    Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative FDG PET/CT in the community: experience from interpretation of outside oncologic PET/CT exams in referred cancer patients.
    Tahari AK; Wahl RL
    J Med Imaging Radiat Oncol; 2014 Apr; 58(2):183-8. PubMed ID: 24314055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
    Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
    J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients.
    Dimitrakopoulou-Strauss A; Pan L; Strauss LG
    Cancer Imaging; 2012 Sep; 12(1):283-9. PubMed ID: 23033440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures.
    Makris NE; Huisman MC; Kinahan PE; Lammertsma AA; Boellaard R
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1507-15. PubMed ID: 23754762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.
    Weber WA; Gatsonis CA; Mozley PD; Hanna LG; Shields AF; Aberle DR; Govindan R; Torigian DA; Karp JS; Yu JQ; Subramaniam RM; Halvorsen RA; Siegel BA; ;
    J Nucl Med; 2015 Aug; 56(8):1137-43. PubMed ID: 25908829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.
    Boellaard R; O'Doherty MJ; Weber WA; Mottaghy FM; Lonsdale MN; Stroobants SG; Oyen WJ; Kotzerke J; Hoekstra OS; Pruim J; Marsden PK; Tatsch K; Hoekstra CJ; Visser EP; Arends B; Verzijlbergen FJ; Zijlstra JM; Comans EF; Lammertsma AA; Paans AM; Willemsen AT; Beyer T; Bockisch A; Schaefer-Prokop C; Delbeke D; Baum RP; Chiti A; Krause BJ
    Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):181-200. PubMed ID: 19915839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.
    Kitajima K; Suenaga Y; Sugimura K
    Jpn J Radiol; 2015 Dec; 33(12):776-89. PubMed ID: 26507982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
    Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
    J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on: "FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging, version 1.0".
    Saboury B; Torigian DA; Alavi A
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1430-1; author reply 1432-3. PubMed ID: 20503048
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
    Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
    Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [
    Lopci E; Hicks RJ; Dimitrakopoulou-Strauss A; Dercle L; Iravani A; Seban RD; Sachpekidis C; Humbert O; Gheysens O; Glaudemans AWJM; Weber W; Wahl RL; Scott AM; Pandit-Taskar N; Aide N
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2323-2341. PubMed ID: 35376991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines. A national survey of PET/CT operations in Austria.
    Rausch I; Bergmann H; Geist B; Schaffarich M; Hirtl A; Hacker M; Beyer T
    Nuklearmedizin; 2014; 53(6):242-8. PubMed ID: 25131649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (18)F-FDG PET/CT imaging in granulomatosis with polyangiitis.
    De Geeter F; Gykiere P
    Hell J Nucl Med; 2016; 19(1):5-6. PubMed ID: 26929934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of FDG and FDG-labeled leukocytes PET/CT in diagnosis of infection.
    Yilmaz S; Aliyev A; Ekmekcioglu O; Ozhan M; Uslu L; Vatankulu B; Sager S; Halaç M; Sönmezoğlu K
    Nuklearmedizin; 2015; 54(6):262-71. PubMed ID: 26503832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.
    Gámez-Cenzano C; Pino-Sorroche F
    PET Clin; 2014 Apr; 9(2):117-27. PubMed ID: 25030277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.